Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28596
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDinh, Thien-
dc.contributor.authorPanopoulos, Harris-
dc.contributor.authorPoniger, Stan-
dc.contributor.authorScott, Andrew M-
dc.date2021-12-28-
dc.date.accessioned2022-01-18T04:46:13Z-
dc.date.available2022-01-18T04:46:13Z-
dc.date.issued2022-03-
dc.identifier.citationApplied Radiation and Isotopes 2022; 181: 110052en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28596-
dc.description.abstract86Y (t1/2 = 14.74 h, 32% β+) has significant potential in theranostic applications as a simultaneous PET imaging partner to 90Y-labelled antibody therapy. However, the complex and costly nature of producing 86Y has led to this radiometal being difficult for hospitals and researchers to obtain. The aim of this work was to develop a simple and cost-efficient method for safely producing 86Y. Our approach was twofold: to develop a method of target preparation that would significantly increase the cost efficiency of producing 86Y, and to design and construct an automated purification system that would eliminate manual radiation handling risks and exposure. Multiple automated productions of high radionuclidic purity (99.45%) 86Y were performed resulting in saturation yields of between 518 MBq/μA and 1332 MBq/μA, dependent on target thickness.en
dc.language.isoeng-
dc.subjectCyclotronen
dc.subjectIsotopeen
dc.subjectSolid targeten
dc.subjectYttrium-86en
dc.titleAutomated processing of solid target 86Y using enriched SrO powder.en
dc.typeJournal Articleen
dc.identifier.journaltitleApplied Radiation and Isotopes : including data, instrumentation and methods for use in agriculture, industry and medicineen
dc.identifier.affiliationMolecular Imaging and Therapyen
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationFaculty of Medicine, University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Melbourne, Australiaen
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35032841/en
dc.identifier.doi10.1016/j.apradiso.2021.110052en
dc.type.contentTexten
dc.identifier.orcid0000-0002-6656-295Xen
dc.identifier.orcid0000-0001-5208-8225en
dc.identifier.pubmedid35032841-
local.name.researcherPoniger, Stan
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

44
checked on Dec 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.